Industry: Medical Devices & Consumables
Published Date: 2024-04-19
Pages: 122 Pages
Report ld: 2983017
Request Sample
Customized Report
Diabetes Testing Program Market Size(US$)

CAGR 2024-2030
7.5%
Market Size,2030
USD 3,871
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
The global Diabetes Testing Program revenue was US$ 2336 million in 2023 and is forecast to a readjusted size of US$ 3871 million by 2030 with a CAGR of 7.5% during the review period (2024-2030).
In United States the Diabetes Testing Program revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Diabetes Testing Program market, also covers the segmentation data of other regions in regional level and county level.
The Global key players of Diabetes Testing Program include Roche, LifeScan, Abbott Laboratories, etc. The top three players hold a share over 44%. China is the largest market, and has a share about 33%. In terms of product type, HbA1c Test is the largest segment, which occupied for a share of about 66%. For application, Home Test is the largest segment, which has a share about 42%.
Global Diabetes Testing Program Scope and Market Size
Diabetes Testing Program market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Testing Program market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Diabetes Testing Program market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces Diabetes Testing Program definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Diabetes Testing Program companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue of Diabetes Testing Program in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6: Americas by Type, by Application and by country, revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetes Testing Program revenue, gross margin, and recent development, etc.
Chapter 11: Analyst's Viewpoints/Conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Diabetes Testing Program Product Introduction
1.2 Global Diabetes Testing Program Outlook, 2019 VS 2023 VS 2030
1.2.1 Global Diabetes Testing Program Market Size for the Year 2019-2030
1.2.2 United States Diabetes Testing Program Market Size for the Year 2019-2030
1.3 Diabetes Testing Program Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.3.1 The Market Share of United States Diabetes Testing Program in Global, 2019 VS 2023 VS 2030
1.3.2 The Growth Rate of Diabetes Testing Program Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4 Diabetes Testing Program Market Dynamics
1.4.1 Diabetes Testing Program Industry Trends
1.4.2 Diabetes Testing Program Market Drivers
1.4.3 Diabetes Testing Program Market Challenges
1.4.4 Diabetes Testing Program Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Diabetes Testing Program by Type
2.1 Diabetes Testing Program Market by Type
2.1.1 HbA1c Test
2.1.2 Finger-prick Test
2.2 Global Diabetes Testing Program Market Size by Type (2019, 2023 & 2030)
2.3 Global Diabetes Testing Program Market Size by Type (2019-2030)
2.4 United States Diabetes Testing Program Market Size by Type (2019, 2023 & 2030)
2.5 United States Diabetes Testing Program Market Size by Type (2019-2030)
3 Diabetes Testing Program by Application
3.1 Diabetes Testing Program Market by Application
3.1.1 Medical Diagnosis
3.1.2 Home Test
3.1.3 Lab Testing
3.2 Global Diabetes Testing Program Market Size, by Application (2019, 2023 & 2030)
3.3 Global Diabetes Testing Program Market Size by Application (2019-2030)
3.4 United States Diabetes Testing Program Market Size by Application (2019, 2023 & 2030)
3.5 United States Diabetes Testing Program Market Size by Application (2019-2030)
4 Global Diabetes Testing Program Competitor Landscape by Company
4.1 Global Diabetes Testing Program Market Size by Company
4.1.1 Global Key Companies of Diabetes Testing Program, Ranked by Revenue (2023)
4.1.2 Global Diabetes Testing Program Revenue by Player (2019-2024)
4.2 Global Diabetes Testing Program Concentration Ratio (CR)
4.2.1 Diabetes Testing Program Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Companies of Diabetes Testing Program in 2023
4.2.3 Global Diabetes Testing Program Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Diabetes Testing Program Head office and Area Served
4.4 Global Key Players of Diabetes Testing Program, Product and Application
4.5 Global Key Players of Diabetes Testing Program, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Diabetes Testing Program Market Size by Company
4.7.1 Key Players of Diabetes Testing Program in United States, Ranked by Revenue (2023)
4.7.2 United States Diabetes Testing Program Revenue by Players (2022, 2023 & 2024)
5 Global Diabetes Testing Program Market Size by Region
5.1 Global Diabetes Testing Program Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Diabetes Testing Program Market Size by Region (2019-2030)
5.2.1 Global Diabetes Testing Program Market Size by Region: 2019-2024
5.2.2 Global Diabetes Testing Program Market Size by Region: 2025-2030
6 Americas
6.1 Americas Diabetes Testing Program Market Size YoY Growth 2019-2030
6.2 Americas Diabetes Testing Program Market Size by Type
6.2.1 Americas Diabetes Testing Program Market Size by Type (2019-2024)
6.2.2 Americas Diabetes Testing Program Market Size by Type (2025-2030)
6.2.3 Americas Diabetes Testing Program Market Share by Type (2019-2030)
6.3 Americas Diabetes Testing Program Market Size by Application
6.3.1 Americas Diabetes Testing Program Market Size by Application (2019-2024)
6.3.2 Americas Diabetes Testing Program Market Size by Application (2025-2030)
6.3.3 Americas Diabetes Testing Program Market Share by Application (2019-2030)
6.4 Americas Diabetes Testing Program Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Diabetes Testing Program Market Size YoY Growth 2019-2030
7.2 EMEA Diabetes Testing Program Market Size by Type
7.2.1 EMEA Diabetes Testing Program Market Size by Type (2019-2024)
7.2.2 EMEA Diabetes Testing Program Market Size by Type (2025-2030)
7.2.3 EMEA Diabetes Testing Program Market Share by Type (2019-2030)
7.3 EMEA Diabetes Testing Program Market Size by Application
7.3.1 EMEA Diabetes Testing Program Market Size by Application (2019-2024)
7.3.2 EMEA Diabetes Testing Program Market Size by Application (2025-2030)
7.3.3 EMEA Diabetes Testing Program Market Share by Application (2019-2030)
7.4 EMEA Diabetes Testing Program Market Facts & Figures by Region (2019, 2023 & 2030)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Diabetes Testing Program Market Size by Type
8.1.1 China Diabetes Testing Program Market Size by Type (2019-2024)
8.1.2 China Diabetes Testing Program Market Size by Type (2025-2030)
8.1.3 China Diabetes Testing Program Market Share by Type (2019-2030)
8.2 China Diabetes Testing Program Market Size by Application
8.2.1 China Diabetes Testing Program Market Size by Application (2019-2024)
8.2.2 China Diabetes Testing Program Market Size by Application (2025-2030)
8.2.3 China Diabetes Testing Program Market Share by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Diabetes Testing Program Market Size YoY Growth 2019-2030
9.2 APAC Diabetes Testing Program Market Size by Type
9.2.1 APAC Diabetes Testing Program Market Size by Type (2019-2024)
9.2.2 APAC Diabetes Testing Program Market Size by Type (2025-2030)
9.2.3 APAC Diabetes Testing Program Market Share by Type (2019-2030)
9.3 APAC Diabetes Testing Program Market Size by Application
9.3.1 APAC Diabetes Testing Program Market Size by Application (2019-2024)
9.3.2 APAC Diabetes Testing Program Market Size by Application (2025-2030)
9.3.3 APAC Diabetes Testing Program Market Share by Application (2019-2030)
9.4 APAC Diabetes Testing Program Market Facts & Figures by Region (2019, 2023 & 2030)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 ASEAN
9.4.5 India
10 Key Players Profiles
10.1 Roche
10.1.1 Roche Company Details
10.1.2 Roche Business Overview
10.1.3 Roche Diabetes Testing Program Introduction
10.1.4 Roche Revenue in Diabetes Testing Program Business (2019-2024)
10.1.5 Roche Recent Development
10.2 LifeScan
10.2.1 LifeScan Company Details
10.2.2 LifeScan Business Overview
10.2.3 LifeScan Diabetes Testing Program Introduction
10.2.4 LifeScan Revenue in Diabetes Testing Program Business (2019-2024)
10.2.5 LifeScan Recent Development
10.3 Abbott Laboratories
10.3.1 Abbott Laboratories Company Details
10.3.2 Abbott Laboratories Business Overview
10.3.3 Abbott Laboratories Diabetes Testing Program Introduction
10.3.4 Abbott Laboratories Revenue in Diabetes Testing Program Business (2019-2024)
10.3.5 Abbott Laboratories Recent Development
10.4 Ascensia
10.4.1 Ascensia Company Details
10.4.2 Ascensia Business Overview
10.4.3 Ascensia Diabetes Testing Program Introduction
10.4.4 Ascensia Revenue in Diabetes Testing Program Business (2019-2024)
10.4.5 Ascensia Recent Development
10.5 Arkray
10.5.1 Arkray Company Details
10.5.2 Arkray Business Overview
10.5.3 Arkray Diabetes Testing Program Introduction
10.5.4 Arkray Revenue in Diabetes Testing Program Business (2019-2024)
10.5.5 Arkray Recent Development
10.6 I-SENS
10.6.1 I-SENS Company Details
10.6.2 I-SENS Business Overview
10.6.3 I-SENS Diabetes Testing Program Introduction
10.6.4 I-SENS Revenue in Diabetes Testing Program Business (2019-2024)
10.6.5 I-SENS Recent Development
10.7 Omron
10.7.1 Omron Company Details
10.7.2 Omron Business Overview
10.7.3 Omron Diabetes Testing Program Introduction
10.7.4 Omron Revenue in Diabetes Testing Program Business (2019-2024)
10.7.5 Omron Recent Development
10.8 Braun
10.8.1 Braun Company Details
10.8.2 Braun Business Overview
10.8.3 Braun Diabetes Testing Program Introduction
10.8.4 Braun Revenue in Diabetes Testing Program Business (2019-2024)
10.8.5 Braun Recent Development
10.9 Siemens
10.9.1 Siemens Company Details
10.9.2 Siemens Business Overview
10.9.3 Siemens Diabetes Testing Program Introduction
10.9.4 Siemens Revenue in Diabetes Testing Program Business (2019-2024)
10.9.5 Siemens Recent Development
10.10 Bio-Rad Laboratories
10.10.1 Bio-Rad Laboratories Company Details
10.10.2 Bio-Rad Laboratories Business Overview
10.10.3 Bio-Rad Laboratories Diabetes Testing Program Introduction
10.10.4 Bio-Rad Laboratories Revenue in Diabetes Testing Program Business (2019-2024)
10.10.5 Bio-Rad Laboratories Recent Development
10.11 Tosoh
10.11.1 Tosoh Company Details
10.11.2 Tosoh Business Overview
10.11.3 Tosoh Diabetes Testing Program Introduction
10.11.4 Tosoh Revenue in Diabetes Testing Program Business (2019-2024)
10.11.5 Tosoh Recent Development
10.12 Danaher Corporation
10.12.1 Danaher Corporation Company Details
10.12.2 Danaher Corporation Business Overview
10.12.3 Danaher Corporation Diabetes Testing Program Introduction
10.12.4 Danaher Corporation Revenue in Diabetes Testing Program Business (2019-2024)
10.12.5 Danaher Corporation Recent Development
10.13 Trinity Biotech
10.13.1 Trinity Biotech Company Details
10.13.2 Trinity Biotech Business Overview
10.13.3 Trinity Biotech Diabetes Testing Program Introduction
10.13.4 Trinity Biotech Revenue in Diabetes Testing Program Business (2019-2024)
10.13.5 Trinity Biotech Recent Development
10.14 HUMAN Diagnostics
10.14.1 HUMAN Diagnostics Company Details
10.14.2 HUMAN Diagnostics Business Overview
10.14.3 HUMAN Diagnostics Diabetes Testing Program Introduction
10.14.4 HUMAN Diagnostics Revenue in Diabetes Testing Program Business (2019-2024)
10.14.5 HUMAN Diagnostics Recent Development
10.15 Terumo
10.15.1 Terumo Company Details
10.15.2 Terumo Business Overview
10.15.3 Terumo Diabetes Testing Program Introduction
10.15.4 Terumo Revenue in Diabetes Testing Program Business (2019-2024)
10.15.5 Terumo Recent Development
10.16 Sinocare
10.16.1 Sinocare Company Details
10.16.2 Sinocare Business Overview
10.16.3 Sinocare Diabetes Testing Program Introduction
10.16.4 Sinocare Revenue in Diabetes Testing Program Business (2019-2024)
10.16.5 Sinocare Recent Development
10.17 Acon Biotech
10.17.1 Acon Biotech Company Details
10.17.2 Acon Biotech Business Overview
10.17.3 Acon Biotech Diabetes Testing Program Introduction
10.17.4 Acon Biotech Revenue in Diabetes Testing Program Business (2019-2024)
10.17.5 Acon Biotech Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Diabetes Testing Program market size was US$ 2674 million in 2025 and is forecast to reach a readjusted size of US$ 4414 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 105
USD 4250.00
(Single User License)
The global Diabetes Testing Program market was valued at US$ 2674 million in 2025 and is anticipated to reach US$ 4414 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 126
USD 2900.00
(Single User License)
The global market for Diabetes Testing Program was estimated to be worth US$ 2674 million in 2025 and is projected to reach US$ 4414 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 137
USD 3950.00
(Single User License)
The global Diabetes Testing Program market size was US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 104
USD 4250.00
(Single User License)
The global Diabetes Testing Program market is projected to grow from US$ 2504 million in 2024 to US$ 4134 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 152
USD 4900.00
(Single User License)
The global market for Diabetes Testing Program was estimated to be worth US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 129
USD 3950.00
(Single User License)
The global market for Diabetes Testing Program was valued at US$ 2504 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published Date: 2025-01-19
Pages: 92
USD 2900.00
(Single User License)
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published Date: 2024-04-19
Pages: 125
USD 3950.00
(Single User License)
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published Date: 2024-04-19
Pages: 99
USD 2900.00
(Single User License)
Published Date: 2024-03-20
Pages: 197
USD 4900.00
(Single User License)
The global Diabetes Testing Program market size was US$ 2674 million in 2025 and is forecast to reach a readjusted size of US$ 4414 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 105
The global Diabetes Testing Program market was valued at US$ 2674 million in 2025 and is anticipated to reach US$ 4414 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-01-05
Pages: 126
The global market for Diabetes Testing Program was estimated to be worth US$ 2674 million in 2025 and is projected to reach US$ 4414 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-01-05
Pages: 137
The global Diabetes Testing Program market size was US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 104
The global Diabetes Testing Program market is projected to grow from US$ 2504 million in 2024 to US$ 4134 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 152
The global market for Diabetes Testing Program was estimated to be worth US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 129
The global market for Diabetes Testing Program was valued at US$ 2504 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published: 2025-01-19
Pages: 92
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published: 2024-04-19
Pages: 125
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published: 2024-04-19
Pages: 99
Published: 2024-03-20
Pages: 197
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now